Endothelial Function-guided Therapy Compared to Usual Care in Patients With NOCAD

NCT02313987 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2016-02-24

No results posted yet for this study

Summary

The current study is designed to test the hypothesis that compared to conventional treatment; endothelial function-guided treatment reduces adverse cardiovascular events in patients with non-obstructive coronary artery disease documented at clinically indicated coronary angiography.

Conditions

  • Coronary Atherosclerosis

Sponsors & Collaborators

  • Itamar-Medical, Israel

    lead INDUSTRY

Principal Investigators

  • Amir Lerman, M.D; Prof · Mayo Clinic

Eligibility

Min Age
20 Years
Max Age
79 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-06-30
Primary Completion
2018-06-30
Completion
2018-12-31

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02313987 on ClinicalTrials.gov